Duet of Death: Biventricular Thrombus in a Methamphetamine User

We present the case of a 60-year-old male who developed an ischemic stroke due to left ventricular (LV) thrombus emboli as a complication of methamphetamine-induced cardiomyopathy. The patient had a history of methamphetamine abuse, hypertension, and ischemic stroke with no residual deficits presented with new onset slurred speech, left-sided weakness, and numbness for two hours. Computed tomography (CT) of the head showed no acute changes, and a tissue plasminogen activator was given in the emergency department within 30 minutes of arrival. Urine drug screen (UDS) was positive for methamphetamine, and magnetic resonance imaging (MRI) of the brain showed acute cortical infarcts in the right frontal lobe and parietal lobe and chronic infarct in the left occipital lobe. Transthoracic echocardiography showed bilateral ventricular thrombus and severely reduced ejection fraction of 20-25%. The patient had no evidence of thrombophilia and was started on a heparin drip for thrombus and goal-directed medical therapy for heart failure with reduced ejection fraction (HFrEF). Upon discharge, the patient was prescribed the oral anticoagulant rivaroxaban. The LV thrombus emboli were attributed to causing ischemic stroke. This case highlights the potential risk of ischemic stroke due to LV thrombus emboli in patients with methamphetamine-induced cardiomyopathy.

[1]  Haowen Jiang,et al.  Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials , 2023, Journal of clinical pharmacology.

[2]  U. Elkayam,et al.  Clinical Characteristics and Management of Methamphetamine‐Associated Cardiomyopathy: State‐of‐the‐Art Review , 2020, Journal of the American Heart Association.

[3]  C. Kramer,et al.  Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi. , 2020, JAMA cardiology.

[4]  M. Akçakaya,et al.  Long-Term Embolic Outcomes After Detection of Left Ventricular Thrombus by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging: A Matched Cohort Study. , 2019, Circulation. Cardiovascular imaging.

[5]  R. Perea,et al.  Cardiac Magnetic Resonance as an Alternative to Endomyocardial Biopsy to Predict Recoverability of Left Ventricular Function in Methamphetamine- Associated Cardiomyopathy. , 2017, JACC. Heart failure.

[6]  G. Schuler,et al.  Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy. , 2017, JACC. Heart failure.

[7]  J. Garot,et al.  Incidence, diagnostic methods, and evolution of left ventricular thrombus in patients with anterior myocardial infarction and low left ventricular ejection fraction: a prospective multicenter study. , 2015, American heart journal.

[8]  R. Kim,et al.  LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR. , 2011, JACC. Cardiovascular imaging.

[9]  Richard D. White,et al.  Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. , 2006, American heart journal.

[10]  S. Dymarkowski,et al.  Visualization of Ventricular Thrombi With Contrast-Enhanced Magnetic Resonance Imaging in Patients With Ischemic Heart Disease , 2002, Circulation.

[11]  Sumbal Zaidi,et al.  Multiple Biventricular Thrombi Associated With Methamphetamine-Associated Cardiomyopathy , 2022, Ochsner Journal.

[12]  R. Janardhanan,et al.  Methamphetamine Cardiotoxicity: Unique Presentation with Multiple Bi-Ventricular Thrombi. , 2016, The American journal of medicine.